T1	dosage 1009 1013	8 oz
T2	drug 1024 1035	fluconazole
T3	pharmacokinetics 1039 1055	CYP2C9 inhibitor
T4	enzyme 1039 1045	CYP2C9
T5	dosage 1092 1096	8 oz
T6	food 1100 1105	water
T7	drug 1116 1127	Flubiprofen
T8	pharmacokinetics 1128 1141	hydroxylation
T9	population 1142 1150	in vitro
T10	interaction 1151 1162	was reduced
T11	other 1155 1162	reduced
T12	value 1163 1176	to 11% +/- 8%
T13	food 1206 1216	brewed tea
T14	value 1218 1231	to 10% +/- 7%
T15	food 1246 1257	grape juice
T16	value 1259 1273	to 56% +/- 16%
T17	food 1288 1303	cranberry juice
T18	value 1305 1318	to 85% +/- 5%
T19	food 1333 1357	cranberry juice placebo,
T20	value 1362 1375	to 21% +/- 6%
T21	drug 1410 1424	sulfaphenazole
T22	drug 1487 1499	Flurbiprofen
T23	drug 15 27	flurbiprofen
T24	pharmacokinetics 1500 1509	clearance
T25	pharmacokinetics 1529 1550	elimination half-life
T26	interaction 1567 1581	did not differ
T27	studyType 158 170	case reports
T28	pharmacokinetics 1634 1643	clearance
T29	drug 1651 1662	fluconazole
T30	interaction 1711 1718	reduced
T31	studyType 1737 1752	placebo control
T32	pharmacokinetics 1811 1820	half-life
T33	interaction 1825 1834	prolonged
T34	pharmacokinetics 186 198	potentiation
T35	drug 1902 1923	4-hydroxyflurbiprofen
T36	interaction 1944 1951	reduced
T37	drug 1955 1966	fluconazole
T38	food 1999 2010	grape juice
T39	food 2015 2018	tea
T40	drug 202 210	warfarin
T41	pharmacokinetics 2028 2043	CYP2C9 activity
T42	enzyme 2028 2034	CYP2C9
T43	population 2044 2052	in vitro
T44	mode 2068 2077	beverages
T45	enzyme 2086 2092	CYP2C9
T46	pharmacokinetics 2086 2111	CYP2C9-mediated clearance
T47	interaction 211 218	induced
T48	drug 2115 2127	flurbiprofen
T49	population 2131 2137	humans
T50	pharmacokinetics 2148 2175;2190 2205	pharmacokinetic interaction highly unlikely
T51	drug 2181 2189	warfarin
T52	drugEffect 219 234	anticoagulation
T53	food 238 253	cranberry juice
T54	interaction 272 282	inhibition
T55	enzyme 287 317	uman cytochrome P450 (CYP) 2C9
T56	food 33 48	cranberry juice
T57	pharmacokinetics 350 359	clearance
T58	drug 374 398	S-enantiomer of warfarin
T59	drug 390 398	warfarin
T60	food 440 455	cranberry juice
T61	pharmacokinetics 479 494	CYP2C9 activity
T62	enzyme 479 485	CYP2C9
T63	food 50 61	grape juice
T64	studyType 509 529	in vitro and in vivo
T65	mode 557 566	beverages
T66	pharmacokinetics 570 585	CYP2C9 activity
T67	enzyme 570 576	CYP2C9
T68	population 602 624	human liver microsomes
T69	food 63 66	tea
T70	drug 636 648	flurbiprofen
T71	pharmacokinetics 649 662	hydroxylation
T72	studyType 691 705	clinical study
T73	population 706 727	14 healthy volunteers
T74	drug 72 83	fluconazole
T75	dosage 737 743	100 mg
T76	drug 744 756	flurbiprofen
T77	studyType 777 794	crossover fashion
T78	drug 842 854	Flurbiprofen
T79	studyType 85 114	in vitro and clinical studies
T80	mealTime 855 867	was preceded
T81	food 909 932	cranberry juice placebo
T82	dosage 934 938	8 oz
T83	food 945 960	cranberry juice
T84	dosage 962 966	8 oz
T85	food 973 983	brewed tea
T86	dosage 985 989	8 oz
T87	food 996 1007	grape juice
#11	AnnotatorNotes T11	événement
#58	AnnotatorNotes T58	métabolite
A1	valence T10 Diminution
A2	valence T30 Diminution
A3	valence T26 Négation
A4	valence T36 Diminution
R1	enzyme_inhibition Arg1:T13 Arg2:T7	
R2	enzyme_inhibition Arg1:T15 Arg2:T7	
R3	enzyme_inhibition Arg1:T17 Arg2:T7	
R4	enzyme_inhibition Arg1:T19 Arg2:T7	
R5	enzyme_inhibition Arg1:T38 Arg2:T48	
R6	enzyme_inhibition Arg1:T39 Arg2:T48	
